Filing Details

Accession Number:
0000937556-18-000100
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-06-01 18:09:03
Reporting Period:
2018-05-31
Accepted Time:
2018-06-01 18:09:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
937556 Masimo Corp MASI Electromedical & Electrotherapeutic Apparatus (3845) 330368882
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1198927 Sanford Fitch C/O Masimo Corporation
52 Discovery
Irvine CA 92618
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-05-31 1,583 $99.05 63,832 No 4 M Direct
Common Stock Disposition 2018-06-01 2,000 $100.21 61,832 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2018-05-31 1,583 $99.05 1,583 $0.00
Common Stock Restricted Stock Units Acquisiton 2018-05-31 1,413 $0.00 1,413 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-05-31 2027-06-01 No 4 M Direct
1,413 2028-05-31 No 4 A Direct
Footnotes
  1. The shares covered by this Form 4 were sold pursuant to a Rule 10b5-1 Sales Plan dated as of November 29, 2017, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
  2. The price reported in Column 4 represents the weighted average sale price per share. The actual sale prices ranged from a low of $99.47 per share to a high of $100.88 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. Each restricted stock unit (RSU) represents the contingent right to receive one share of common stock of the Issuer upon vesting of the RSU.
  4. These RSUs were granted on June 1, 2017 and vested in full on May 31, 2018, the date of the next annual meeting of stockholders following the date of the grant.
  5. These RSUs were granted on May 31, 2018 and will vest in full on the earlier of the first anniversary of the grant date or the date of the next annual meeting of stockholders following the date of the grant.